New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
08:53 EDTDISH, QIHU, IBM, NVS, STO, UBS, BA, SSNLF, AAPL, BLK, CS, AIG, AMGNOn the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: Dish (DISH) to pull LightSquared bid...Lenders use social media to check borrowers' creditworthiness...A U.S.-EU trade war could break out over online privacy...Hong Kong stock exchange to rethink IPOs after Alibaba views...AIG (AIG) extends expiration of tax asset plan to 2017...REUTERS: Credit Suisse (CS) bets on a turnaround for money-losing U.S. brokerage...BlackRock (BLK), NY attorney general agreement ends analyst surveys...Apple (AAPL), Samsung (SSNLF) CEOs to attend mediation in U.S. patent fight...Boeing (BA) machinists want new vote, allege unfair labor practices...BLOOMBERG: Regulators consider Volcker exemption for smaller banks' CDOs...UBS (UBS) may spin off investment bank...As Norway loosens control, Statoil (STO) looks abroad for deals (Businessweek)...Samsung (SSNLF) sees Galaxy S5 by April, studies eye scanner...FINANCIAL TIMES: Novartis (NVS) facing criminal investigation in Japan over drug advertising...IBM (IBM) to create new $1B Watson business unit...CHINA DAILY: Qihoo 360 (QIHU) denies Alibaba interested in investing...SFGATE: Explosion reported at Amgen (AMGN).
News For DISH;AIG;CS;BLK;AAPL;SSNLF;BA;UBS;STO;NVS;IBM;QIHU;AMGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all recent news | >>
October 8, 2014
11:41 EDTSSNLF, AAPLJ.C. Penney says store base count 'roughly' where it needs to be
Says evaluating stores to see if EBITDA accretive. Says "disciplined" regarding promotions. Says won't risk margin over promotions. Says Apple (AAPL), Samsung (SSNLF), Amazon (AMZN) taking "chunk" out of consumer spending. Sees returning to 37%-39% gross margins over time.
11:05 EDTNVSLeerink pharmaceuticals analyst holds an analyst/industry conference call
Analyst discusses congestive heart failure and the prospects for LCZ696 in HF-PEF on an Analyst/Industry conference call to be held on October 9 at 3 pm.
10:44 EDTAAPLFitbit said it has no plans to integrate with iOS 8 Heath app, 9to5Mac says
Subscribe for More Information
10:20 EDTAMGNAmgen biosimilar franchise underappreciated, says Piper Jaffray
After Amgen announced positive Phase 3 results for its biosimilar Humira in psoriasis, Piper Jaffray said it believes that Amgen's overall pipeline is underappreciated since the company's biosimilar franchise is generally not included in consensus estimates. The firm views Amgen as a top large cap picks and reiterate its Overweight rating on the stock.
09:57 EDTAAPLBlog reveals next-generation Apple iPad Air, 9to5Mac says
Subscribe for More Information
09:38 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:16 EDTAMGNAmgen's ABP 501 for psoriasis shows positive Phase 3 results
Subscribe for More Information
08:20 EDTAAPLQualcomm opportunity at Xiaomi almost rivals iPhone, says FBR Capital
Subscribe for More Information
08:19 EDTBAAerCap reports 134 aircraft transactions completed during Q3
AerCap Holdings (AER) announced the completion of 134 aircraft transactions during Q3. Signed lease agreements for 84 aircraft. Delivered 26 aircraft under contracted lease agreements. Purchased nine new aircraft, including five Boeing (BA) 787-8s, three Boeing 737-800s and one Airbus (EADSY) A321-200. Executed sale and part-out transactions for 15 aircraft, including: one Airbus A300-600F, one Airbus A340-300, eight Boeing B737 classics, one Boeing B767-300ER and two MD-11s from AerCap's owned portfolio. One Boeing 737 classic and one Airbus A320-200 from AerCap's managed portfolio. Signed financing transactions for $1.5B, including the previously announced private offering of $800M. The total financing transactions completed year-to-date amount to $8.9B.
08:00 EDTBLKBlackRock volatility increases into Q3 and guidance
Subscribe for More Information
07:36 EDTUBSPeterson Institute for International Economics to hold a discussion
Board of Directors Chairman of UBS AG, Axel Weber, discusses whether the global economy can heal and if inflation will make a comeback in 2015 in a webcast being held on October 8 at 12:15 pm. Webcast Link
07:22 EDTIBMIBM to make renewed push around 'Watson' AI system, FT reports
Subscribe for More Information
07:19 EDTNVS, AMGNCBI to hold a conference
Subscribe for More Information
07:13 EDTCSBank dealers agree to revised derivatives rules, FT reports
Subscribe for More Information
07:11 EDTAMGNEuropean Academy of Dermatology and Venereology to hold a conference
23rd EADV Congress is being held in Amsterdam, The Netherlands on October 8-12.
06:57 EDTAAPLApple's iPhone 6 Plus more popular than iPhone 6, WantChinaTimes says
Subscribe for More Information
06:13 EDTSSNLF, AAPLNon-Apple notebook, tablet demand to be weak till 2Q15, DigiTimes reports
Demand for non-Apple (AAPL) notebooks and tablets may remain weak until the second quarter of 2015, reports DigiTimes. Citing Taiwan makers, the pressure due to booming sales from Apple products may decrease sales until Microsoft (MSFT) launches Windows 10 next year. Demand for Samsung (SSNLF), Sony (SNE) , And HTC smartphones have also dropped worldwide recently. Reference Link
06:11 EDTNVSNovartis says expects three executive committee members to leave
Novartis (NVS) confirmed that following completion of the transactions with GlaxoSmithKline (GSK) and Eli Lilly and Company (LLY) in the coming months, that the three business leaders of the Novartis divisions at the center of the transaction will leave the Executive Committee of Novartis. The expected changes to the ECN are subject to the closing of the transactions announced on April 22 - Novartis expects the transaction with GSK to be completed in the first half of 2015, and the transaction with Eli Lilly for its Animal Health Business to close in the first quarter of 2015. George Gunn, currently Division Head, Novartis Animal Health, will reach his contractual retirement age in July 2015 and will retire from Novartis. Upon closing of the Animal Health transaction with Lilly he will leave the ECN. Brian McNamara, currently Division Head, Novartis OTC, will transition to GSK as Head of Americas and Europe for the consumer health businesses, reporting to the President of GSK Consumer Healthcare, effective at closing of the transaction. Andrin Oswald, currently Division Head, Novartis Vaccines, will be leaving Novartis to pursue other opportunities following closing of the transaction with GSK.
06:10 EDTAAPLQuantom begins small-volume production of 12-inch Macbook Air, DigiTimes says
Subscribe for More Information
05:54 EDTAAPLTeen interest in Apple Watch 'tepid,' says Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use